Jump to content
Knowledge Hub

MHRA - Decommission of eSUSAR

5th August 2022


The MHRA is retiring the eSUSAR website in favour for Individual Case Safety Reports (ICSR) Submissions - providing users a more robust, stringent, and transparent way of expediting suspected unexpected serious adverse drug reactions (SUSARs) from Clinical Trials of Investigational Medicinal Products.

Read More

Back to News Archive


Virtual Event Platform